Cargando…

Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins

The MYC family oncogenes (MYC, MYCN, and MYCL) contribute to the genesis of many human cancers. Among them, amplification of the MYCN gene and over-expression of N-Myc protein are the most reliable risk factors in neuroblastoma patients. On the other hand, we previously found that a peptide derived...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasada, Manabu, Iyoda, Takuya, Asayama, Tatsufumi, Suenaga, Yusuke, Sakai, Shunsuke, Kase, Naoya, Kodama, Hiroaki, Yokoi, Sana, Isohama, Yoichiro, Fukai, Fumio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697639/ https://www.ncbi.nlm.nih.gov/pubmed/31452837 http://dx.doi.org/10.18632/oncotarget.27131

Ejemplares similares

Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide
por: Fujita, Motomichi, et al.
Publicado: (2020)

Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via β1-Integrin Activation in Fibroblasts
por: Fujita, Motomichi, et al.
Publicado: (2019)

Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation
por: Iyoda, Takuya, et al.
Publicado: (2012)

Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells
por: Fujita, Motomichi, et al.
Publicado: (2019)

The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration
por: Suzuki, Hideo, et al.
Publicado: (2017)

N-myc gene expression and oncoprotein characterisation in medulloblastoma.
por: Garson, J. A., et al.
Publicado: (1989)

Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb
Publicado: (1992)

HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?
por: Đukić, Anamaria, et al.
Publicado: (2020)

Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein
por: Beaulieu, Marie-Eve, et al.
Publicado: (2020)

Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma
por: Iyoda, Takuya, et al.
Publicado: (2020)

Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway
por: Gain, Chandrima, et al.
Publicado: (2020)

The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer.
por: Watson, J. V., et al.
Publicado: (1986)

Peroxynitrite promotes serine-62 phosphorylation-dependent stabilization of the oncoprotein c-Myc
por: Raman, Deepika, et al.
Publicado: (2020)

The Diarylheptanoid Curcumin Induces MYC Inhibition and Cross-Links This Oncoprotein to the Coactivator TRRAP
por: Mödlhammer, Alexander, et al.
Publicado: (2021)

Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler
por: Woodley, Chase M., et al.
Publicado: (2021)

C-Terminal Domain of Aquaporin-5 Is Required to Pass Its Protein Quality Control and Ensure Its Trafficking to Plasma Membrane
por: Muroi, Shin-ichi, et al.
Publicado: (2021)

Ezrin Regulates Ca(2+) Ionophore-Induced Plasma Membrane Translocation of Aquaporin-5
por: Muroi, Shin-ichi, et al.
Publicado: (2021)

Ubiquitination-dependent, proteasomal degradation of the retroviral oncoprotein Tax by niclosamide, an anti-helminthic molecule
por: Xiang, Di, et al.
Publicado: (2014)

MYC and integrins interplay in colorectal cancer
por: Boudjadi, Salah, et al.
Publicado: (2016)

Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression
por: Fujita, Motomichi, et al.
Publicado: (2021)

DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein
por: An, Jing, et al.
Publicado: (2008)

Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin.
por: Lymboussaki, A., et al.
Publicado: (1996)

Boiogito, a Kampo medicine, improves hydrarthrosis in a rat model of knee osteoarthritis
por: Fujitsuka, Naoki, et al.
Publicado: (2015)

Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma
por: Yamaki, Tomohiro, et al.
Publicado: (2013)

Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.
por: Hendy-Ibbs, P., et al.
Publicado: (1987)

Over-expression of c-Myc oncoprotein in oral squamous cell carcinoma in the South Indian population
por: Pai, RB, et al.
Publicado: (2009)

SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of cMYC oncoprotein
por: Geng, Chuandong, et al.
Publicado: (2017)

The MYC oncoprotein directly interacts with its chromatin cofactor PNUTS to recruit PP1 phosphatase
por: Wei, Yong, et al.
Publicado: (2022)

Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins
por: Chi, Ya-Hui, et al.
Publicado: (2021)

UBXN2A enhances CHIP‐mediated proteasomal degradation of oncoprotein mortalin‐2 in cancer cells
por: Sane, Sanam, et al.
Publicado: (2018)

Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy
por: Sun, Xiao-Xin, et al.
Publicado: (2021)

The lethal giant larvae tumour suppressor mutation requires dMyc oncoprotein to promote clonal malignancy
por: Froldi, Francesca, et al.
Publicado: (2010)

Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance
por: Thomas, Lance R., et al.
Publicado: (2019)

Dual Targeting Oncoproteins MYC and HIF1α Regresses Tumor Growth of Lung Cancer and Lymphoma
por: Huang, Xiaohu, et al.
Publicado: (2021)

Docosahexaenoic acid induces the degradation of HPV E6/E7 oncoproteins by activating the ubiquitin–proteasome system
por: Jing, K, et al.
Publicado: (2014)

ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
por: Chen, Yu, et al.
Publicado: (2016)

The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zinc-finger protein-1
por: Morandell, Dieter, et al.
Publicado: (2012)

Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors
por: Tran, Huy Minh, et al.
Publicado: (2020)

Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells
por: Huang, H-L, et al.
Publicado: (2017)

Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
por: Lankes, Katharina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ccq53naa61o3uigleovjf6l3s